GlassScriptPhysician profile
David M Fenig
NPI 1437318557
$26,092.48
in general payments reported to CMS, 2019-2025
63 companies · $1,892 in 2025
The $1,892 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,356 · 2020: $769 · 2021: $10K · 2022: $1,854 · 2023: $2,009 · 2024: $1,914 · 2025: $1,892.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,815.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $16,156.10 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Sumitomo Pharma America, INC. | $924.80 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $903.40 | 2019-2025 | Myrbetriq, Xtandi |
| Abbvie INC. | $646.04 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $645.04 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $620.00 | 2019-2024 | Aveed, Edex, Xiaflex |
| Janssen Biotech, INC. | $476.55 | 2019-2025 | Erleada, Akeega, Balversa |
| Teleflex LLC | $451.31 | 2021-2025 | Urolift, Barrigel |
| Medtronic, INC. | $390.12 | 2021-2024 | Interstim |
| Progenics Pharmaceuticals, INC. | $362.27 | 2022-2025 | Pylarify |
| Coloplast Corp | $361.38 | 2019-2025 | Speedicath |
| Urovant Sciences INC | $322.78 | 2021-2022 | |
| Urogen Pharma, INC. | $278.39 | 2022-2025 | Jelmyto |
| Boston Scientific Corporation | $278.03 | 2019-2024 | Ams 700 |
| Zyla Life Sciences, INC. | $232.94 | 2019 |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $224.91 | 2024-2025 | Aveed, Xiaflex, Edex |
| Merck Sharp & Dohme LLC | $217.01 | 2022-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Tolmar, INC. | $204.31 | 2023-2024 | |
| Dendreon Pharmaceuticals LLC | $194.30 | 2019-2025 | Provenge |
| Pfizer INC. | $177.85 | 2019-2025 | |
| Immunitybio, INC. | $135.17 | 2025 | |
| Rigicon,INC. | $115.19 | 2023 | Rigi10 Malleable Penile Prosthesis |
| Accord Healthcare, INC. | $102.58 | 2023-2025 | |
| Allergan, INC. | $99.58 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $98.30 | 2019-2025 | Adstiladrin |
| Mission Pharmacal Company | $94.72 | 2022-2023 | Uribel |
| Tolmar Pharmaceuticals, INC. | $87.82 | 2021-2022 | |
| Convatec INC. | $86.74 | 2021 | |
| Halozyme INC | $82.49 | 2023 | |
| Therapeuticsmd, INC. | $77.86 | 2019-2021 | |
| Myovant Sciences INC. | $69.91 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $66.60 | 2020-2023 | Erleada |
| Laborie Medical Technologies Corp. | $63.42 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Tempus Ai, INC | $59.97 | 2024-2025 | Xt Cdx |
| 180 Medical, INC. | $59.03 | 2020-2022 | |
| Medtronic USA, INC. | $55.04 | 2019-2020 | |
| Axonics, INC. | $52.29 | 2020-2023 | Axonics |
| Myriad Genetic Laboratories, INC. | $47.67 | 2021 | |
| Clarus Therapeutics INC. | $45.50 | 2021 | |
| Azurity Pharmaceuticals, INC. | $41.88 | 2025 | Azmiro, Horizant |
| Olympus America INC. | $41.12 | 2023-2024 | Itind System |
| Sun Pharmaceutical Industries INC. | $39.45 | 2024-2025 | |
| Acerus Pharmaceuticals Corporation | $35.01 | 2020-2022 | |
| Vertex Pharmaceuticals Incorporated | $32.37 | 2025 | |
| Organon LLC | $30.11 | 2025 | |
| Becton, Dickinson and Company | $27.95 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Foundation Medicine, INC. | $25.22 | 2023 | Foundationone Liquid Cdx |
| Dentsply Ih INC. | $25.03 | 2019 | |
| Metuchen Pharmaceuticals | $22.97 | 2019-2020 | |
| Renovia INC | $21.81 | 2019 | |
| Neotract INC. | $21.15 | 2019 | |
| Verity Pharmaceuticals INC. | $19.52 | 2025 | Tlando |
| Novartis Pharmaceuticals Corporation | $19.41 | 2023 | |
| Calyxo, INC. | $19.33 | 2025 | Cvac Aspiration System |
| Avadel Specialty Pharmaceuticals, LLC | $18.50 | 2019 | |
| Palette Life Sciences, INC. | $17.26 | 2022 | |
| Telix Pharmaceuticals | $15.61 | 2024 | Illuccix |
| Hollister Incorporated | $14.97 | 2023 | Vapro Pocket |
| Millicent US INC | $13.04 | 2023 | Intrarosa, Femring |
| Aytu Biopharma, INC. | $12.56 | 2019 | |
| Duchesnay USA Incorporated | $10.80 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$361,837.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Fenig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.